Clinical trial
Advancing Varenicline as a Treatment for Cannabis Use Disorder
NCT02892110 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advancing Varenicline as a Treatment for Cannabis Use Disorder
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 13, 2017
- Completion date
- November 27, 2018
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
substance use disorder